Letroz 2.5 mg Tablets contain Letrozole, a potent non-steroidal aromatase inhibitor used primarily for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen production in the body, thereby slowing or stopping the growth of estrogen-dependent cancer cells. Letroz may also be used off-label for ovulation induction in certain cases of female infertility.

• Effective treatment for hormone-sensitive breast cancer

• Helps reduce the risk of cancer recurrence

• May support ovulation in women undergoing fertility treatment (off-label use)

• Oral formulation ensures convenient daily use

Take Letroz 2.5 mg exactly as prescribed by your healthcare provider. It is usually taken once daily, with or without food. Swallow the tablet whole with a glass of water. Try to take the medication at the same time each day for consistent blood levels.

• For breast cancer treatment: 2.5 mg once daily, typically continued for several years

• For fertility treatment (off-label): Dosage and duration vary and must be supervised by a fertility specialist
  Never exceed the prescribed dose. Follow your doctor's instructions strictly.

• Not recommended for premenopausal women unless under specialist guidance

• Contraindicated in pregnancy and breastfeeding

• Use with caution in patients with osteoporosis or liver impairment

• Routine monitoring of bone mineral density may be required during long-term use

• Inform your doctor about all other medications you are taking to avoid interactions

• Common side effects may include:

• Hot flashes

• Fatigue

• Less commonly, it may affect bone density or raise cholesterol levels. Seek medical advice if symptoms are persistent or severe.

• Headache or dizziness

• Joint or muscle pain

• Increased sweating

• Store Letroz tablets at room temperature below 25°C.
   
• Keep them in a dry place away from direct light and moisture.
   
• Ensure the medicine is out of reach of children.

Q: What is Letroz used for?
A: Letroz is mainly used to treat hormone receptor-positive breast cancer in postmenopausal women. It may also be used in fertility treatment for ovulation induction.

Q: Can Letroz be used during pregnancy?
A: No, Letroz is contraindicated during pregnancy and breastfeeding due to its hormonal effects.

Q: How long should I take Letroz for breast cancer?
A: Treatment duration is typically 5 years or as advised by your oncologist based on your response and medical history.

Q: Does Letroz cause menopause-like symptoms?
A: Yes, common side effects include hot flashes, fatigue, and joint pain, which are similar to menopause symptoms.